Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells DOI Creative Commons
Sofia Rossini, Sara Ambrosino, Claudia Volpi

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Янв. 25, 2024

The tryptophan-degrading enzyme indoleamine 2,3-dioxygenase 1 (IDO1) is a plastic immune checkpoint molecule that potently orchestrates responses within the tumor microenvironment (TME). As heme-containing protein, IDO1 catalyzes conversion of essential amino acid tryptophan into immunoactive metabolites, called kynurenines. By depleting and enriching TME with kynurenines, catalytic activity shapes an immunosuppressive TME. Accordingly, inducible or constitutive expression in cancer correlates negative prognosis for patients, representing one critical tumor-escape mechanisms. However, clinically trialed inhibitors disappointed expected anti-tumor efficacy. Interestingly, non-enzymatic apo-form still active as transducing capable promoting immunoregulatory phenotype dendritic cells (DCs) well pro-tumorigenic behavior murine melanoma. Moreover, inhibitor epacadostat can induce tolerogenic plasmacytoid DCs, overcoming inhibition IDO1. Based on this recent evidence, plasticity was investigated human ovarian cell line, SKOV-3, constitutively expresses dynamic balance between holo- apo-protein, thus potentially endowed dual function (i.e., enzymatic non-enzymatic). Besides inhibiting activity, persistently stabilizes favoring its tyrosine-phosphorylation association phosphatase SHP-2. In SKOV-3 cells, both these early molecular events activate signaling pathway transduced by which independent contributes to tumorigenic cells. Overall, our findings unveiled new mechanism action target, repositioning stabilizer IDO1, tumor. This could contribute clarify lack effectiveness clinical trials shed light innovative immunotherapeutic strategies tackle target.

Язык: Английский

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies DOI Creative Commons
Qian Zhou,

Yu Meng,

Daishi Li

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Март 8, 2024

Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal accumulation iron-dependent membrane-localized lipid peroxides. It acts as an innate tumor suppressor mechanism and participates in biological processes tumors. Intriguingly, mesenchymal dedifferentiated cancer cells, which are usually resistant to apoptosis traditional therapies, exquisitely vulnerable ferroptosis, further underscoring its potential treatment approach for cancers, especially refractory cancers. However, impact ferroptosis on extends beyond direct cytotoxic effect cells. induction not only inhibits but also promotes development due negative anticancer immunity. Thus, comprehensive understanding role crucial successful translation therapy from laboratory clinical applications. In this review, we provide overview recent advancements cancer, covering molecular mechanisms, functions, regulatory pathways, interactions with microenvironment. We summarize applications immunotherapy, radiotherapy, systemic therapy, well inhibition various conditions. finally discuss markers, current challenges future directions cancer.

Язык: Английский

Процитировано

185

To metabolomics and beyond: a technological portfolio to investigate cancer metabolism DOI Creative Commons
Federica Danzi,

Raffaella Pacchiana,

Andrea Mafficini

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Март 22, 2023

Abstract Tumour cells have exquisite flexibility in reprogramming their metabolism order to support tumour initiation, progression, metastasis and resistance therapies. These reprogrammed activities include a complete rewiring of the bioenergetic, biosynthetic redox status sustain increased energetic demand cells. Over last decades, cancer field has seen an explosion new biochemical technologies giving more tools than ever before navigate this complexity. Within cell or tissue, metabolites constitute direct signature molecular phenotype thus profiling concrete clinical applications oncology. Metabolomics fluxomics, are key technological approaches that mainly revolutionized enabling researchers both qualitative mechanistic model cancer. Furthermore, upgrade from bulk single-cell analysis provided unprecedented opportunity investigate biology at cellular resolution allowing depth quantitative complex heterogenous diseases. More recently, advent functional genomic screening allowed identification pathways, processes, biomarkers novel therapeutic targets concert with other allow patient stratification treatment regimens. This review is intended be guide for metabolism, highlighting current emerging technologies, emphasizing advantages, disadvantages potential leading development innovative anti-cancer

Язык: Английский

Процитировано

121

Immune regulation through tryptophan metabolism DOI Creative Commons
Su‐Kil Seo, Byungsuk Kwon

Experimental & Molecular Medicine, Год журнала: 2023, Номер 55(7), С. 1371 - 1379

Опубликована: Июль 3, 2023

Amino acids are fundamental units of molecular components that essential for sustaining life; however, their metabolism is closely interconnected to the control systems cell function. Tryptophan (Trp) an amino acid catabolized by complex metabolic pathways. Several resulting Trp metabolites bioactive and play central roles in physiology pathophysiology. Additionally, various physiological functions mutually regulated gut microbiota intestine coordinately maintain intestinal homeostasis symbiosis under steady state conditions during immune response pathogens xenotoxins. Cancer inflammatory diseases associated with dysbiosis- host-related aberrant inactivation aryl hydrocarbon receptor (AHR), which a several metabolites. In this review, we focus on mechanisms through converges AHR activation modulation function restoration tissue how these processes can be targeted using therapeutic approaches cancer autoimmune diseases.

Язык: Английский

Процитировано

117

Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth DOI Creative Commons
Dong Liu, Chunhui Liang, Bin Huang

и другие.

Advanced Science, Год журнала: 2023, Номер 10(6)

Опубликована: Янв. 10, 2023

Abstract Emerging evidence reveals that amino acid metabolism plays an important role in ferroptotic cell death. The conversion of methionine to cysteine is well known protect tumour cells from ferroptosis upon starvation through transamination. However, whether acids‐produced metabolites participate independent the pathway largely unknown. Here, authors show tryptophan serotonin (5‐HT) and 3‐hydroxyanthranilic (3‐HA) remarkably facilitate escape distinct cysteine‐mediated inhibition. Mechanistically, both 5‐HT 3‐HA act as potent radical trapping antioxidants (RTA) eliminate lipid peroxidation, thereby inhibiting Monoamine oxidase A (MAOA) markedly abrogates protective effect via degrading 5‐HT. Deficiency MAOA renders cancer resistant treatment. Kynureninase (KYNU), which essential for production, confers death, whereas 3‐hydroxyanthranilate 3,4‐dioxygenase (HAAO) significantly blocks mediated inhibition by consuming 3‐HA. In addition, expression level HAAO positively correlated with peroxidation clinical outcome. Together, findings demonstrate works a new anti‐ferroptotic promote growth, targeting this will be promising therapeutic approach

Язык: Английский

Процитировано

91

Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition DOI
Weiwei Cui, Meng Guo, Dong Liu

и другие.

Nature Cell Biology, Год журнала: 2024, Номер 26(1), С. 124 - 137

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

75

SIRT1 activated by AROS sensitizes glioma cells to ferroptosis via induction of NAD+ depletion-dependent activation of ATF3 DOI Creative Commons
Xi Chen, Zhenchuan Wang, Chen Li

и другие.

Redox Biology, Год журнала: 2024, Номер 69, С. 103030 - 103030

Опубликована: Янв. 3, 2024

Ferroptosis is a type of programmed cell death resulting from iron overload-dependent lipid peroxidation, and could be promoted by activating transcription factor 3 (ATF3). SIRT1 an enzyme accounting for removing acetylated lysine residues target proteins consuming NAD+, but its role remains elusive in ferroptosis ATF3. In this study, we found was activated during the process RSL3-induced glioma ferroptosis. Moreover, aggravated activator SRT2183, suppressed SIRT inhibitor EX527 or when silenced with siRNA. These indicated sensitized cells to Furthermore, expressional upregulation nuclear translocation Silence ATF3 siRNA attenuated increases ferrous downregulation SLC7A11 GPX4 depletion cysteine GSH. Thus, inducting activation. Mechanistically, activation reinforced decline NAD+ FK866 that inhibit NAD + synthesis via salvage pathway, intracellular maintained at higher level supplement exogenous NAD+. Notably, caused RSL3 enhanced further inhibited EX527. consumption Finally, inducing reactive oxygen species-dependent AROS. Together, our study revealed AROS sensitizes ATF3-dependent inhibition GPX4.

Язык: Английский

Процитировано

25

Thirty years of NRF2: advances and therapeutic challenges DOI
Donna D. Zhang

Nature Reviews Drug Discovery, Год журнала: 2025, Номер unknown

Опубликована: Март 4, 2025

Язык: Английский

Процитировано

11

Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway DOI Creative Commons
Jiangfang Lian, Hangyuan Guo,

Zuoquan Zhong

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2025, Номер 29(2)

Опубликована: Янв. 1, 2025

ABSTRACT The clinical application of doxorubicin (DOX) is limited due to its cardiotoxicity, which primarily attributed interaction with iron in mitochondria, leading lipid peroxidation and myocardial ferroptosis. This study aimed investigate the role gut microbiota‐derived metabolite, indole‐3‐lactic acid (ILA), mitigating DOX‐induced cardiotoxicity (DIC). Cardiac function, pathological changes, ferroptosis were assessed vivo. cardioprotective effects mechanisms ILA explored using multi‐omics approaches, including single‐nucleus RNA sequencing (snRNA‐seq) bulk RNA‐seq, further validated Nrf2 knockout mice. findings revealed that DOX treatment disrupted microbiota, significantly reducing levels tryptophan metabolite ILA. In DIC models, supplementation markedly improved cardiac reduced collagen deposition, mitigated atrophy. snRNA‐seq analyses indicated played a crucial Experimental data demonstrated decreased both mice DOX‐treated H9C2 cells, evidenced by restoration GPX4 SLC7A11 reduction ACSL4. Mechanistically, functions as ligand for aryl hydrocarbon receptor (AhR), upregulation expression. protective against abolished silencing AhR. Moreover, beneficial on eliminated Nrf2‐deficient conclusion, exerts therapeutic inhibiting through activation AhR/Nrf2 signalling pathway. Identifying microbial could offer viable strategies DIC.

Язык: Английский

Процитировано

4

IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression DOI Creative Commons
Qianting Tian,

Guixue Dan,

Xuyan Wang

и другие.

Cell Death Discovery, Год журнала: 2025, Номер 11(1)

Опубликована: Янв. 25, 2025

Язык: Английский

Процитировано

3

IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer DOI Creative Commons
Leonie Zeitler, Peter J. Murray

Journal of Biological Chemistry, Год журнала: 2023, Номер 299(6), С. 104827 - 104827

Опубликована: Май 23, 2023

Regulated tryptophan metabolism by immune cells has been associated with the promotion of tolerance and poor outcomes in cancer. The main focus research centered on local depletion IDO1, an intracellular heme-dependent oxidase that converts to formyl-kynurenine. This is first step a complex pathway supplying metabolites for de novo NAD+ biosynthesis, 1-carbon metabolism, myriad kynurenine derivatives which several act as agonists arylhydrocarbon receptor (AhR). Thus, express IDO1 deplete while generating downstream metabolites. We now know another enzyme, secreted L-amino acid IL4i1 also generates bioactive from tryptophan. In tumor microenvironments, have overlapping expression patterns, especially myeloid cells, suggesting two enzymes control network tryptophan-specific metabolic events. New findings about shown both generate suite suppress oxidative cell death ferroptosis. within inflammatory environments, simultaneously essential amino depletion, AhR activation, suppression ferroptosis, biosynthesis key intermediates. Here, we summarize recent advances this field, focusing speculate inhibition remains viable adjuvant therapy solid tumors, effects must be accounted for, potentially may need inhibited at same time produce positive cancer therapy. 20 proteinogenic acids sustain cellular biochemistry by: (i) translation, (ii) source carbon skeletons nitrogen energy generation nucleotide (iii) "shuttles" move molecules different compartments tasks such malate-aspartate shuttle or methionine major methyl donor 1-carbon-folate cycle. Several dedicated additional functions precursors signaling (neurotransmitters), cofactors (heme, glycine), redox protective glutathione (from glycine, cysteine, glutamate). Because these diverse functions, balance their sources synthesis, transport, scavenging protein sinks therefore constantly monitor deficiencies excesses all acids. An facet concerns biochemical where regulated enzyme consumes distinct products. setting, events occur simultaneously: can become limiting, triggering defenses including increased reduction activation autophagy (and related measures) products modulatory effects. define "regulated" here specific, induced activity metabolizing via cytokines, pathogen products, other pathways, acquisition not normally present type interest. case latter, many patterns differ origin, presumably way obtain resources growth evade control. acid-metabolizing cytokines are arginases (ARG1 cytoplasm ARG2 mitochondria), oxidases (indole, 2,3 dioxygenase), TDO2 (tryptophan dioxygenase) (Interleukin 4-induced 1, oxidase) (1Murray P.J. Amino auxotrophy system immunological nodes.Nat. Immunol. 2016; 17: 132-139Google Scholar). Three constitutive functions: ARG1 metabolize dietary arginine hepatocytes, most some mitochondria. However, system, highly expressed thereby consume microenvironments unexpected Scholar, 2Grohmann U. Bronte V. Control response metabolism.Immunol. Rev. 2010; 236: 243-264Google Accordingly, intersect elements regulation biology. types, uncoupled regulatory signals cells: discuss aspect briefly counterpoint metabolism. note intersection microbial indoles microbiota, host physiology emerging important topic (3Hezaveh K. Shinde R.S. Klotgen A. Halaby M.J. Lamorte S. Ciudad M.T. et al.Tryptophan-derived activate aryl hydrocarbon tumor-associated macrophages anti-tumor immunity.Immunity. 2022; 55: 324-340.e8Google 4Roager H.M. Licht T.R. Microbial catabolites health disease.Nat. Commun. 2018; 9: 3294Google element too large scope included herein. IL4i1. Summaries biology clinical significance arginase published 5Platten M. Nollen E.A.A. Rohrig U.F. Fallarino F. Opitz C.A. Tryptophan common therapeutic target cancer, neurodegeneration beyond.Nat. Drug Discov. 2019; 18: 379-401Google 6Peranzoni E. Marigo I. Dolcetti L. Ugel Sonda N. Taschin al.Role immunity immunopathology.Immunobiology. 2007; 212: 795-812Google 7Eming S.A. Murray Pearce E.J. Metabolic orchestration wound healing response.Cell Metab. 2021; 33: 1726-1743Google Scholar) will covered. Nevertheless, general sense, arginine- tryptophan-metabolizing cause similar outputs: consumed product generated. regard, practical conceptual issues underline experimental First, realm, quantification intrinsically temporal versus experimentally often environments. do yet full understanding cell-specific limitation, vary cell. Indeed, substantial differences adaptation malignant (8Shorthouse D. Bradley J. Critchlow S.E. Bendtsen C. Hall B.A. Heterogeneity line landscape.Mol. Syst. Biol. 18e11006Google Scholar), normal muscle neuron T naturally requirements linked specific functions. Further, only rudimentary how detect (9Wolfson R.L. Sabatini D.M. dawn age sensors mTORC1 pathway.Cell 2017; 26: 301-309Google adjust correct amounts needed. Second, curiosity arginases, IDO1/TDO2 IL4i1, tryptophan-centric nature compared threonine branched-chain specificity suggests degradation pathways evolved immune-specific relative As here, knowledge newly discovered rapidly advancing. it limitation For example, valine specifically collapses one electron transport chain (10Thandapani P. Kloetgen Witkowski Glytsou Lee A.K. Wang al.Valine tRNA levels availability regulate I assembly leukaemia.Nature. 601: 428-433Google eliminates stem bone marrow (11Taya Y. Ota Wilkinson A.C. Kanazawa Watarai H. Kasai al.Depleting permits nonmyeloablative mouse hematopoietic transplantation.Science. 354: 1152-1155Google cases, controlled manipulation food media rather than controls degradation. By contrast, depends natural endogenous limitation. upregulated locally depleting aromatic acids) immunomodulatory microenvironment (Fig. 1A). While (12Boulland M.L. Marquet Molinier-Frenkel Moller Guiter Lasoudris al.Human IL4I1 L-phenylalanine mature dendritic inhibits T-lymphocyte proliferation.Blood. 110: 220-227Google each occurs spatially separated manner. operate catabolize intra- extracellular milieu. catalyzes oxidation indole ring N-formyl-kynurenine rate-limiting reaction (Kyn) pathway. Kyn supplies substrates synthesis (13Covarrubias A.J. Perrone R. Grozio Verdin NAD(+) its roles processes during ageing.Nat. Mol. Cell 22: 119-141Google 14Cervenka Agudelo L.Z. Ruas J.L. Kynurenines: tryptophan's exercise, inflammation, mental health.Science. 357eaaf9794Google 15Badawy A.A. Kynurenine metabolism: functional aspects.Int. Res. 101178646917691938Google 1B). N-formyl-Kyn subsequently deformylated constitutively arylformamidase (AFMID) formyl group (16Newman Falcone Huerta Uribe Zhang T. Athineos Pietzke al.Immune-regulated Ido1-dependent one-carbon units pancreatic stellate cells.Mol. Cell. 81: 2290-2302.e7Google branch pathway, converted into 3-hydroxykynurenine (3HK) monooxygenase (KMO) further 3-hydroxyanthranilic (3HAA) kynureninase (KYNU). Subsequently, 3-hydroxyanthranilate-3,4-dioxygenase (HAAO) 2-amino-3-carboxymuconic semialdehyde (2ACS) 3HAA, spontaneously cyclize quinolinic (QA), picolinic glutaryl-CoA. Glutaryl-CoA feeds Krebs cycle, whereas QA substrate kynurenic (KynA) aminotransferase (KAT) isoenzymes (15Badawy KynA ligands (AhR), ligand-activated transcription factor involved multitude physiological (17Gutierrez-Vazquez Quintana F.J. Regulation receptor.Immunity. 48: 19-33Google discussed detail later. A notable KYNU KAT isozymes require pyridoxyl 5′-phosphate (active vitamin B6) cofactor could play role regulating output branches Overall, catalyzing modulate availability, emergence metabolites, fuels tryptophan-derived units. conjunction ultimately determine flux final Therefore, single relevant thus appears underexplored Besides catalyze IDO2, homolog IDO1. genes encoding IDO2 located tandem arrangement, they ancestral gene (18Yuasa H.J. Ball Ho Y.F. Austin C.J. Whittington C.M. Belov al.Characterization evolution vertebrate indoleamine 2, 3-dioxygenases IDOs monotremes marsupials.Comp. Biochem. Physiol. B 2009; 153: 137-144Google 19Metz Duhadaway J.B. Kamasani Laury-Kleintop Muller Prendergast G.C. Novel catabolic Ido2 preferred antitumor 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.Cancer 67: 7082-7087Google exhibits much lower catalytic (Km 500–1000 fold lower) limited information context immunoregulation (20Mondanelli G. Mandarano Belladonna Suvieri Pelliccia Bellezza al.Current challenges immunotherapy.Front. 12679953Google 21Merlo L.M.F. Peng W. DuHadaway Montgomery J.D. al.The mediates autoimmune arthritis through nonenzymatic mechanism.J. 208: 571-581Google isoenzyme review. mainly liver responsible ∼90% nutritional types (notably gliomas) resistance (22Ye Z. Yue Shi Shao Wu Role Ido TDO cancers diseases implications.J. Cancer. 10: 2771-2782Google (LAAO) responses was described 1997 (23Chu C.C. Paul W.E. Fig1, interleukin isolated cDNA representational difference analysis.Proc. Natl. Acad. Sci. 1997; 94: 2507-2512Google IL-4-inducible murine cells. producers (DCs) (24Marquet Cousin Puiffe Martin-Garcia Baud al.Dichotomy between factors inducing immunosuppressive IL-4-induced 1 (IL4I1) lymphocytes mononuclear phagocytes.Eur. 40: 2557-2568Google extensively below. respects, unfortunate name confused IL-4 receptor. Moreover, peripherally since expression, protein's function indicated. relatives snake venoms, provided us clue mammalian (25Zeitler Fiore Meyer Russier Zanella Suppmann al.Anti-ferroptotic mechanism IL4i1-mediated metabolism.Elife. 10e64806Google describe called LAAOs. official mammals. contrast additionally metabolizes phenylalanine tyrosine 25Zeitler 26Sadik Somarribas Patterson L.F. Ozturk Mohapatra S.R. Panitz Secker P.F. al.IL4I1 checkpoint activates AHR promotes progression.Cell. 2020; 182: 1252-1270.e34Google 27Mason J.M. Naidu M.D. Barcia Porti Chavan S.S. Chu gene-1 leukocyte unusual acidic pH preference lysosomal localization.J. 2004; 173: 4561-4567Google fact, shows highest affinity towards studies others suggest central mediated IL4i1-dependent 28Zhang X. Gan Li Su Tan al.Endogenous pyruvate IL4I1.J. Agric. Food Chem. 68: 10678-10684Google LAAOs, FAD-dependent deamination α-keto acids, hydrogen peroxide (H2O2), ammonia (29Castellano overview l-amino bacteria mammals: immunoregulatory IL4I1.Molecules. 2151Google LAAOs organisms vertebrates but plants, bacteria, fungi, gained attention component venoms (30Du X.Y. Clemetson K.J. Snake venom oxidases.Toxicon. 2002; 659-665Google mediate cytotoxicity H2O2 (31Suhr S.M. Kim D.S. Identification substance induces apoptosis.Biochem. Biophys. 1996; 224: 134-139Google 32Ande Kommoju P.R. Draxl Murkovic Macheroux Ghisla al.Mechanisms induction oxidase, ophidian venom.Apoptosis. 2006; 11: 1439-1451Google 33Burin Berzoti-Coelho M.G. Cominal J.G. Ambrosio Torqueti M.R. Sampaio S.V. calloselasma rhodostoma modulates apoptomiRs Bcr-Abl-positive lines.Toxicon. 120: 9-14Google 34Costal-Oliveira Stransky Guerra-Duarte Naves Souza D.L. Vivas-Ruiz D.E. Yarleque al.L-amino bothrops atrox triggers autophagy, apoptosis necrosis human keratinocytes.Sci. Rep. 781Google When enzymatic recombinant Indian cobra (Naja naja) LAAO, found sufficient toxic production ammonia, catabolism phenylalanine, tyrosine, produces phenylpyruvate (PP), 4-hydroxyphenylpyruvate (4HPP), indole-3-pyruvate (I3P), respectively Out I3P greatest anti-oxidative properties secreted, space requires subsequent import well-resolved little known I3P, recently reported give rise KynA, indole-3-acetic (I3AA), indole-3-aldehyde (I3A) indole-3-lactate (I3L) (26Sadik (non-transformed) baseline negligible. Instead, inducible. After stimulation 2 interferons (IFNs), IFN-γ, transcript thousands above STAT1 (35Fiore regulation.Curr. Opin. 70: 7-14Google 36Fiore Zeitler Gross Hiller M.K. Parker al.Kynurenine importation SLC7A11 propagates anti-ferroptotic signaling.Mol. 82: 920-932.e927Google 37Chon S.Y. Hassanain H.H. Pine Gupta S.L. Involvement interferon-gamma-regulated gene.J. Interferon Cytokine 1995; 15: 517-526Google 38Du M.X. Sotero-Esteva W.D. Taylor M.W. Analysis IFN-gamma.J. 2000; 20: 133-142Google any responds IFN-γ cell-type difficult tease apart. Depending analyzed, underestimated (39Desvignes Ernst Interferon-gamma-responsive nonhematopoietic Mycobacterium tuberculosis.Immunity. 31: 974-985Google centers biology, (especially ovarian endometrial tumors) property readily observed single-cell RNA sequencing (scRNAseq) datasets foundational concept behind use inhibitors (40Van den Eynde B.J. Van Baren Baurain J.F. Is there future Ido1 after failure epacadostat melanoma?.Annu. Cancer 4: 241-256.10Google restore immunity, blocked tryptophan-deficient milieu resulting IDO1+ expressing question tumor-specific transcriptional involvement IFN-independent driving open up new opportunities manipulating (TME) (41Hennequart Pilotte Cane Hoffmann Stroobant Plaen al.Constitutive tumors driven cyclooxygenase-2 intrinsic cancer.Immunol. 5: 695-709Google 42Theate van Moulin Larrieu Renauld J.C. al.Extensive profiling tumoral tissues 2015; 3: 161-172Google 43Uyttenhove Theate Colau Parmentier al.Evidence based 2,3-dioxygenase.Nat. Med. 2003; 1269-1274Google point, very understood extrinsic It possible cell-intrinsic "hijack" enhanced survival. So far, questions remain largely unexplored vital answer if properly understand monocyte-derived DCs residing granulomas (TAMs) (44Carbonnelle-Puscian Copie-Bergm

Язык: Английский

Процитировано

42